peptides. These studies demonstrate that amyloidogenic peptides can induce prolonged activation of proapoptotic marker expression in cultured neurons even at sublethal concentrations. These effects could contribute to chronic neuronal dysfunction and increase susceptibility to additional metabolic insults in neurodegenerative disorders. If so, targeting of therapeutic strategies against neuronal caspase activation early in the disease course could be beneficial in AD and prion diseases.
Transmissible spongiform encephalopathies (TSE, also known as prion diseases) such as CreutzfeldtJakob disease (CJD), variant CJD (vCJD), and Gerstmann-Sträussler-Scheinker syndrome (GSS) are characterized by progressive vacuolation of the neuropil, neuronal degeneration, gliosis, and, in some cases, marked deposition of an amyloidogenic conformer of
